2d
Hosted on MSNCagent Vascular Unveils Serranator SL-PRO to Enhance Treatment of Peripheral Artery DiseaseCagent Vascular, Inc. has announced the launch of its latest innovation, the Serranator SL-PROâ„¢ PTA Serration Balloon ...
Overall complication rates were similar to those seen with transfemoral access, however, and patients liked it better.
Women are more likely to have pulmonary arterial hypertension, but men tend to have worse outcomes and worse treatment responses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results